Fluticasone propionate and formoterol fumarate inhaler (IP) is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) by combining a corticosteroid (fluticasone) to reduce airway inflammation and a bronchodilator (formoterol) to relax airway muscles, making breathing easier.
